Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class ASSE: 688266

"Suzhou Zelgen Biopharmaceuticals Co., Ltd."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

· Issued by Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A

All Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A news releases